<?xml version="1.0" encoding="UTF-8"?>
<p>Although it remains an area of controversy, the authors believe that in patients with resolved HBV infection and undetectable baseline serum HBV-DNA, serial monitoring of aminotransferases, HBsAg, or serum HBV-DNA is a preferable alternative to long-term commitment to antiviral prophylaxis.</p>
